rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
BLISS GVS PHARMA LTD. - Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year September 30, 2022
Download announcement < Back
29 Oct 2022
BLISS GVS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2022 ,inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year September 30, 2022. Further, pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company&apos;s Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons, the trading window for dealing in shares of the Company was closed for all the Designated Persons of the Company and their immediate relatives of the Company from October 01, 2022 and shall remain closed until 48 hours after the announcement of unaudited Financial Results of the Company for the quarter and half year September 30, 2022.
View all announcements for BLISS GVS PHARMA LTD. Source: BSE India

Mutual Fund Selector

Find the fund that is right for you